CD86 and neoplasm: In terms of the surface expression quantitated through the median fluorescence intensity (MFI), CD86, CD80, and MHC-I expression on SM1 tumor cells (Figure 5c–e) markedly increased after INAPs-PTT (red) and ICG-PLGA-PTT (blue) treatment compared to controls in vitro.